REGULATE-PCI trial--Author's reply.
Publication
, Journal Article
Lincoff, AM; Alexander, JH; Mehran, R
Published in: Lancet (London, England)
April 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet (London, England)
DOI
EISSN
1474-547X
ISSN
0140-6736
Publication Date
April 2016
Volume
387
Issue
10027
Start / End Page
1510 / 1511
Related Subject Headings
- Percutaneous Coronary Intervention
- Peptide Fragments
- Male
- Humans
- General & Internal Medicine
- Female
- Factor IXa
- Aptamers, Nucleotide
- Anticoagulants
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lincoff, A. M., Alexander, J. H., & Mehran, R. (2016). REGULATE-PCI trial--Author's reply. Lancet (London, England), 387(10027), 1510–1511. https://doi.org/10.1016/s0140-6736(16)00694-2
Lincoff, A Michael, John H. Alexander, and Roxana Mehran. “REGULATE-PCI trial--Author's reply.” Lancet (London, England) 387, no. 10027 (April 2016): 1510–11. https://doi.org/10.1016/s0140-6736(16)00694-2.
Lincoff AM, Alexander JH, Mehran R. REGULATE-PCI trial--Author's reply. Lancet (London, England). 2016 Apr;387(10027):1510–1.
Lincoff, A. Michael, et al. “REGULATE-PCI trial--Author's reply.” Lancet (London, England), vol. 387, no. 10027, Apr. 2016, pp. 1510–11. Epmc, doi:10.1016/s0140-6736(16)00694-2.
Lincoff AM, Alexander JH, Mehran R. REGULATE-PCI trial--Author's reply. Lancet (London, England). 2016 Apr;387(10027):1510–1511.
Published In
Lancet (London, England)
DOI
EISSN
1474-547X
ISSN
0140-6736
Publication Date
April 2016
Volume
387
Issue
10027
Start / End Page
1510 / 1511
Related Subject Headings
- Percutaneous Coronary Intervention
- Peptide Fragments
- Male
- Humans
- General & Internal Medicine
- Female
- Factor IXa
- Aptamers, Nucleotide
- Anticoagulants
- 42 Health sciences